In Oceania, drug production, trafficking and consumption remain overwhelmingly a criminal justice issue. However, Australia and New Zealand have moved towards policies that prioritise health to respond to drug use. More recently, New Zealand made the headlines with the adoption of an innovative policy towards new psychoactive substances.
Experiences of resilience in the face of the challenges imposed on service delivery and clients' health by the COVID-19 pandemic underscore the importance of meaningfully engaging affected communities in responses to adverse events.
Kvamme et al. suggest that a significant proportion of Danish users of cannabis as medicine are motivated by a desire to alleviate their ailments whilst minimising the negative side effects that they associate with legal prescription drugs.
Informed by international case studies, the Scottish government highlights the role of criminalisation in exacerbating harm and undermining health responses, acknowledging the need for a sweeping policy overhaul.